Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer

Cancer

Volumn 118, Issue 4, 2012, Pages 947-959

  Cheung, Kin Fai ^a   Lam, Cleo N Y ^b   Wu, Kaichun ^c   Ng, Enders K O ^b   Chong, Wilson W S ^a   Cheng, Alfred S L ^b   To, Ka Fai ^b   Fan, Daiming ^c   Sung, Joseph J Y ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

diagnosis; epigenetic alteration; gastric cancer; prognosis; ring finger protein 180

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; RING FINGER PROTEIN; RING FINGER PROTEIN 180; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; COMPLEMENTARY DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE SEQUENCE; GENE SILENCING; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MITOSIS INHIBITION; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RING FINGER PROTEIN 180 GENE; STOMACH CANCER; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR GENE; CDKN2A GENE; CELL GROWTH; CLINICAL ARTICLE; COLONY FORMATION; DOWN REGULATION; GENE; GENE LOSS; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN CELL; INTESTINE METAPLASIA; LUCIFERASE ASSAY; MTSS1 GENE; RNF180 GENE; STOMACH CARCINOGENESIS; TIMP3 GENE; UPREGULATION;

AGED; APOPTOSIS; BASE SEQUENCE; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; DOWN-REGULATION; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS; RING FINGER DOMAINS; STOMACH NEOPLASMS; SURVIVAL RATE; UBIQUITIN-PROTEIN LIGASES;

EID: 84856804279     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26189     Document Type: Article

References (26)

1. Jones PA, Baylin SB,. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3: 415-428.
2. Kaneda A, Kaminishi M, Yanagihara K, et al. Identification of silencing of 9 genes in human gastric cancers. Cancer Res. 2002; 62: 6645-6650.
3. Kang GH, Lee HJ, Hwang KS, et al. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol. 2003; 163: 1551-1556.
4. Esteller M,. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002; 21: 5427-5440.
5. Oue N, Mitani Y, Motoshita J, et al. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer. 2006; 106: 1250-1259.
6. Liang G, Gonzalgo ML, Salem C, et al. Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction. Methods. 2002; 27: 150-155.
7. Cheung KF, Lam CN, Leung WK, et al. Epigenetic characterization of a novel tumor suppressor gene, RNF180, in gastric cancer and its application in noninvasive cancer detection. Gastroenterology. 2008; 134 (suppl 1): 382.
8. Ogawa M, Mizugishi K, Ishiguro A, et al. Rines/RNF180, a novel RING finger gene-encoded product, is a membrane-bound ubiquitin ligase. Genes Cells. 2008; 13: 397-409.
9. Reddy BA, Etkin LD, Freemont PS,. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci. 1992; 17: 344-345.
10. Fanelli M, Fantozzi A, De Luca P, et al. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome. J Biol Chem. 2004; 279: 5374-5379.
11. Balastik M, Ferraguti F, Pires-da Silva A, et al. Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration. Proc Natl Acad Sci U S A. 2008; 105: 12016-12021.
12. Neumuller RA, Betschinger J, Fischer A, et al. Mei-P26 regulates microRNAs and cell growth in the Drosophila ovarian stem cell lineage. Nature. 2008; 454: 241-245.
13. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-408.
14. Cheng YY, Yu J, Wong YP, et al. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br J Cancer. 2007; 97: 895-901.
15. Yu J, Cheng YY, Tao Q, et al. Methylation of protocadherin 10, a novel tumor-suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology. 2009; 136: 640-651.
16. Yu J, Tao Q, Cheng YY, et al. Promoter methylation of a Wnt/b-catenin signaling antagonist DKK3 is associated with poor survival of gastric cancer. Cancer. 2009; 115: 49-60.
17. Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem. 2006; 52: 2211-2218.
18. Yu J, Tao Q, Cheung KF, et al. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology. 2008; 48: 508-518.
19. Lalonde JP, Lim R, Ingley E, et al. HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressor. J Biol Chem. 2004; 279: 8181-8189.
20. van Everdink WJ, Baranova A, Lummen C, et al. RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2003; 146: 48-57.
21. Mertens D, Wolf S, Schroeter P, et al. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood. 2002; 99: 4116-4121.
22. Nishikawa H, Wu W, Koike A, et al. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. Cancer Res. 2009; 69: 111-119.
23. Ahonen M, Poukkula M, Baker AH, et al. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene. 2003; 22: 2121-2134.
24. Hemmati PG, Normand G, Gillissen B, et al. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF. Oncogene. 2003; 27: 6707-6709.
25. Eymin B, Leduc C, Coll JL, et al. p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene. 2003; 22: 1822-1835.
26. Parr C, Jiang WG,. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and antimetastatic properties in breast cancer. Eur J Cancer. 2009; 45: 1673-1683.